Crinetics Pharmaceuticals Inc's Chief Scientific Officer Sells Company Shares

On January 25, 2024, Stephen Betz, Chief Scientific Officer of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX), sold 3,000 shares of the company.

Related Keywords

,Crinetics Pharmaceuticals Inc ,Pharmaceutical Company ,Fec Filing ,Chief Scientific Officer ,Endocrine Diseases ,